Oncology & Cancer

Study identifies cancer patients most likely to develop cachexia

It is estimated that as many as 80% of advanced-stage cancer patients may develop cachexia, a potentially fatal metabolic syndrome characterized by extreme weight loss and muscle wasting, but scientists do not yet fully understand ...

Oncology & Cancer

Meningioma molecular profile reliably predicts tumor recurrence

Although typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The current meningioma classification does not consistently predict whether the tumor ...

Oncology & Cancer

Scientists discover molecular key to how cancer spreads

Yale researchers have discovered how metastasis, the spread of cancer cells throughout the body, is triggered on the molecular level, and have developed a tool with the potential to detect those triggers in patients with ...

page 7 from 9